Paxillin and FAK in p130Cas LLPS.
(A & C) EGFP-p130Cas (green) transfected cells immunostained for paxillin (red) (A) and FAK (C). Lower panels show zoomed-in images of the area in the white box. (B & D) Line scans of p130Cas and paxillin (B) / FAK (D) showing co-localization. (E & F) Time lapse images of a cell co-transfected with EGFP-p130Cas (green) and either tagRFP-paxillin (red) (E) or mcherry-FAK (red) (F) showing the co-emergence from a FA of paxillin (E) and FAK (F) with p130Cas. Lower panel: corresponding line intensity profile. (G & H) EGFP-p130Cas in a paxillin-null (G) and FAK-null (H) cell. Right panels show zoomed-in images of the boxed area. (I & J) Image of a p130Cas-null cell transfected with either tagRFP-paxillin (I) or mcherry-FAK (J). Right panels show zoomed-in images of the boxed area. (K) Immunofluorescence image of a cell expressing EGFP-p130Cas (green) stained for phosphorylated p130Cas (purple). (L) Lower panels show zoomed-in images of the boxed area. (M) Corresponding intensity line profile of phosphorylated p130Cas and p130Cas. (N) Ratio of phosphorylated p130Cas to total p130Cas) in FA and droplets. N = 2176 FA and 53 droplets from 10 cells each. Error bars = SEM. (O) Schematic of WT, Y15F mutant, substrate domain deleted (Δ68-456 or ΔSD) and C-terminal domain partly deleted p130Cas (Δ611-742 or C-term). (P) Image of p130Cas-/- cells transfected with EGFP- WT-, Y15F, ΔSD/ Δ68-456 or C-term/ Δ611- 742 p130Cas. (Q) Quantification of percentage of droplet-positive cells for the indicated constructs from N = 7 (N indicates independent experiments) with 146/238, 76/156, 231/347, 56/86, 205/396, 236/430 and 110/284 cells; N = 4 with 82/278, 52/201, 42/184 and 58/238 cells; N = 3 with 38/346, 23/203 and 68/371 cells and N = 3 with 139/287, 142/222 and 134/325 cells respectively. Error bars = SEM. (R) Plot of disorder probability versus amino acid for WT (black) and Y15F mutant (red) mouse p130Cas.Top: Color-coded protein domains.